Q1 2015
Released May 7, 2015, before the open
10-Q filed May 7, 2015, 37 days after period end · 0001144204-15-028164
Q1 2015 · 10-Q
Revenue—
Net Income-$2.96M-$2.96M N/M vs Q1 2014N/M vs Q4 2014
EPS Diluted-$0.23-$0.23 N/M vs Q1 2014no prior Q4 2014 on file
Operating Income-$2,974,239N/M
Operating Cash Flow-$3,025,238N/M
Free Cash Flowderived-$3,038,468N/M
What the release said
The release
Same quarter
| Metric | Q1 2015 | Q1 2014 | Q1 2013 | Q1 2012 |
|---|---|---|---|---|
| Net Income | -$2.96M | -$5.27M | -$1.35M | -$61.23K |
| EPS Diluted | -$0.23 | -$0.41 | -$0.30 | -$0.02 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Lipocine Inc. · CIK 1535955 · Engraved from SEC EDGAR